spironolactone has been researched along with Tricuspid Incompetence in 3 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Excerpt | Relevance | Reference |
---|---|---|
"Their mitral regurgitation (MR) is a result of left ventricular (LV) geometrical distortion." | 1.33 | Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. ( Bolling, SF; Geltz, A; Spoor, MT, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chanoit, G | 1 |
Bublot, I | 1 |
Viguier, E | 1 |
Spoor, MT | 1 |
Geltz, A | 1 |
Bolling, SF | 1 |
Hayashi, Y | 1 |
Ohtani, M | 1 |
Hiraishi, T | 1 |
Kobayashi, Y | 1 |
3 other studies available for spironolactone and Tricuspid Incompetence
Article | Year |
---|---|
Transient tricuspid valve regurgitation following surgical treatment of cor triatriatum dexter in a dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cor Triatriatum; Diuretics; Dog Dis | 2009 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality | 2006 |
Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide.
Topics: Administration, Oral; Atrial Natriuretic Factor; Cardiopulmonary Bypass; Female; Heart Failure; Huma | 2002 |